Key statistics
On Friday, Abeona Therapeutics Inc (PCJ:DUS) closed at 5.75, -20.69% below its 52-week high of 7.25, set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.75 |
---|---|
High | 5.75 |
Low | 5.75 |
Bid | 5.85 |
Offer | 6.10 |
Previous close | 5.70 |
Average volume | 410.20 |
---|---|
Shares outstanding | 43.31m |
Free float | 41.12m |
P/E (TTM) | -- |
Market cap | 277.21m USD |
EPS (TTM) | -2.13 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 07:12 GMT.
More ▼
Announcements
- Abeona Therapeutics® Announces Participation in November Investor Conferences
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
- Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
- Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
- Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
- Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
- Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼